ORKA
Oruka Therapeutics, Inc.
Stock
$84.52+1.10 (+1.32%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $874M | $337M | $37M | $42M | $53M | $49M | $8.4M | $6.6M | $12M | $21M | $39M | $15M | $17M | $2.9M | $5.9M | $7.0M | $7.8M | — | — | — | — | — |
| Current assets | $885M | $344M | $38M | $43M | $54M | $50M | $8.5M | $6.8M | $12M | $21M | $39M | $15M | $17M | $3.0M | $6.2M | $7.2M | — | — | — | — | — | — |
| Total assets | $1.1B | $489M | $38M | $43M | $55M | $50M | $8.5M | $6.8M | $12M | $25M | $40M | $16M | $17M | $3.2M | $6.5M | $8.2M | — | — | — | — | — | — |
| Current liabilities | $23M | $15M | $637K | $1.1M | $3.5M | $3.5M | $926K | $793K | $2.1M | $2.4M | $1.5M | $1.4M | $1.5M | $305K | $754K | $1.2M | — | — | — | — | — | — |
| Total liabilities | $25M | $17M | $841K | $1.4M | $3.9M | $3.9M | $926K | $793K | $2.1M | $2.4M | $1.5M | $1.4M | $1.5M | $305K | $770K | $1.4M | — | — | — | — | — | — |
| Shareholders' equity | $1.1B | $472M | $37M | $42M | $51M | $47M | $7.6M | $6.0M | $10M | $22M | $38M | $15M | $16M | $2.9M | $5.7M | $6.8M | $7.4M | −$38M | −$20M | −$5.7M | −$678K | −$619K |
| Shares outstanding | 66.2M | 49.5M | 14.5M | 14.4M | 14.4M | 14.4M | 1.6M | 18.4M | 13.9M | 9.1M | 9.1M | 3.0M | 3.0M | 455K | 290K | — | — | — | — | — | — | — |
| Current ratio | 38.51 | 22.37 | 59.01 | 37.72 | 15.56 | 14.28 | 9.16 | 8.55 | 5.94 | 8.95 | 25.88 | 11.16 | 11.27 | 9.98 | 8.24 | 6.02 | — | — | — | — | — | — |